Magazine article from our research archive:

Grassley asks FDA to probe Glaxo's Paxil communication.(Ethics)(Brief article)

Sen. Chuck Grassley (R-IA) has asked FDA to dig in on the data that GlaxoSmithKline submitted to the agency about the antidepressant Paxil to determine if the company concealed risk of suicide for users of the drug, "The Wall Street Journal" reported June 12.

Grassley pointed out in a letter to the agency and HHS Secretary Michael Leavitt that the U.K. recently concluded that GSK withheld safety information in its submission for approval in Europe; he wants FDA to investigate whether the company did the same in the U.S. as well.

In Grassley's statement on the Senate floor June 11, he spoke of how drug companies conceal unflattering data. "I don't mean that they ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!